We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+0.53%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$116M
AUM Growth
-$1.44M
Cap. Flow
-$1.6M
Cap. Flow %
-1.38%
Top 10 Hldgs %
24.2%
Holding
184
New
25
Increased
26
Reduced
81
Closed
25

Top Buys

Rank Stock Value
1
VLO icon
Valero Energy
VLO
+$1.1M
2
AZN icon
AstraZeneca
AZN
+$748K
3
NVS icon
Novartis
NVS
+$704K
4
AVT icon
Avnet
AVT
+$701K
5
SYNA icon
Synaptics
SYNA
+$698K

Sector Composition

Rank Sector Weight
1 Healthcare 19.02%
2 Industrials 16.07%
3 Consumer Staples 15.08%
4 Financials 12.64%
5 Consumer Discretionary 12.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AWI icon
51
Armstrong World Industries
AWI
$7.78B
$707K 0.61%
18,050
+1,550
+9% +$63.5K
HBI
52
DELISTED
Hanesbrands
HBI
$691K 0.59%
27,500
+5,900
+27% +$161K
AVT icon
53
Avnet
AVT
$7.94B
$681K 0.59%
+16,800
New +$701K
MS icon
54
Morgan Stanley
MS
$336B
$680K 0.59%
26,164
-13,050
-33% -$341K
PEP icon
55
PepsiCo
PEP
$189B
$678K 0.58%
6,399
-300
-4% -$31K
APD icon
56
Air Products & Chemicals
APD
$66.8B
$657K 0.57%
5,000
+568
+13% +$75.6K
COST icon
57
Costco
COST
$421B
$620K 0.53%
3,950
+1,200
+44% +$182K
KO icon
58
Coca-Cola
KO
$374B
$620K 0.53%
13,673
AMWD
59
DELISTED
American Woodmark
AMWD
$617K 0.53%
9,300
+2,825
+44% +$204K
JPM.PRD.CL
60
DELISTED
JPMorgan Chase & Co.
JPM.PRD.CL
$604K 0.52%
+23,300
New +$594K
PNR icon
61
Pentair
PNR
$11.2B
$602K 0.52%
15,374
-7,259
-32% -$282K
HW
62
DELISTED
Headwaters Inc
HW
$602K 0.52%
+33,531
New +$633K
KSU
63
DELISTED
Kansas City Southern
KSU
$592K 0.51%
6,575
-878
-12% -$79.9K
LLY icon
64
Eli Lilly
LLY
$1.06T
$583K 0.5%
+7,400
New +$557K
CP icon
65
Canadian Pacific Kansas City
CP
$79.3B
$578K 0.5%
22,435
-8,375
-27% -$226K
LHX icon
66
L3Harris
LHX
$53.9B
$576K 0.5%
6,900
-950
-12% -$75K
UPS icon
67
United Parcel Service
UPS
$87.8B
$571K 0.49%
5,300
-250
-5% -$26K
DRI icon
68
Darden Restaurants
DRI
$24.1B
$570K 0.49%
+9,000
New +$589K
AAL icon
69
American Airlines Group
AAL
$10.6B
$553K 0.48%
19,525
-950
-5% -$32.1K
BAC.PRE icon
70
Bank of America Depository Shares Series E
BAC.PRE
$1.48B
$547K 0.47%
+22,450
New +$522K
SYNA icon
71
Synaptics
SYNA
$3.99B
$546K 0.47%
+10,154
New +$698K
CL icon
72
Colgate-Palmolive
CL
$74.1B
$534K 0.46%
7,300
-1,650
-18% -$117K
BMY icon
73
Bristol-Myers Squibb
BMY
$131B
$526K 0.45%
7,150
-9,400
-57% -$664K
HRL icon
74
Hormel Foods
HRL
$13.8B
$522K 0.45%
+14,250
New +$533K
PANW icon
75
Palo Alto Networks
PANW
$293B
$522K 0.45%
25,524
+3,750
+17% +$86.9K

Similar funds

New England Research & Management's Q2 2016 Portfolio in Review

As of Q2 2016, New England Research & Management held 184 positions worth $116M, down 1.2% from $118M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

New England Research & Management's Q2 2016 filing shows 25 new, 26 increased, 81 reduced and 25 closed positions. Its largest new stake was AstraZeneca: 12,875 shares worth $777K. The largest sale was Martin Marietta Materials, an estimated $829K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Industrials and Consumer Staples.

  • New England Research & Management's largest Q2 2016 buy was AstraZeneca: 12,875 shares worth $777K.
  • New England Research & Management added most to Valero Energy in Q2 2016, an estimated $1.1M increase.
  • New England Research & Management's biggest Q2 2016 reduction was Bristol-Myers Squibb, cutting an estimated $664K.
  • New England Research & Management fully exited Martin Marietta Materials in Q2 2016, selling an estimated $829K.
  • New England Research & Management's ten largest holdings make up 24% of its $116M portfolio in Q2 2016.
  • New England Research & Management opened 25 new positions and closed 25 in Q2 2016.
  • New England Research & Management's portfolio value fell 1.2% quarter-over-quarter to $116M.

Based on New England Research & Management's 13F filing for Q2 2016, filed 5 Jul 2016.